A revolution in cancer treatment could soon be underway following a breakthrough that may lead to a dramatic improvement in cancer survival rates.
A new study at the University of Warwick, published today in the journal Angewandte Chemie International Edition, has developed a new drug that can manipulate the body’s natural signalling and energy systems, allowing the body to attack and shut down cancerous cells.
Called ZL105, the drug is a compound based on the precious metal iridium. The study has found ZL105 could potentially replace currently used anticancer drugs, which become less effective over time, cause a wide-range of side-effects and damage healthy cells as well as cancerous.
Commenting on the breakthrough, University of Warwick researcher and study co-author Dr Isolda Romero-Canelon said “The energy-producing machinery in cancer cells works to the limit as it attempts to keep up with quick proliferation and invasion. This makes cancer cells susceptible to minor changes in the cell ‘power-house’. Our drug pushes cancer cells over the limit causing them to slow and shut down, whilst normal cells can cope with its effects”.
Preliminary data indicate that the novel drug may be ten times more effective in treating ovarian, colon, melanoma, renal, and some breast cancers, according to data obtained by the US National Cancer Institute. The researchers now aim to expand the study to cancers that are inherently resistant to existing drugs and to those which have developed resistance after a first round of chemotherapy treatments.
Study co-author Professor Peter J. Sadler said “Existing cancer treatments often become less effective after the first course, as cancer cells learn how they are being attacked. The drug we have developed is a catalyst and is active at low doses. It can attack cancer cells in multiple ways at the same time, so the cancer is less able to adapt to the treatment. This means the new drugs could be much more effective than existing treatments.”
“Platinum-based drugs are used in nearly 50% of all chemotherapeutic regimens, exert their activity by damaging DNA and cannot select between cancerous and non-cancerous cells, leading to a wide-range of side-effects from renal failure to neurotoxicity, ototoxicity, nausea and vomiting.
“In contrast, the new iridium-based drug is specifically designed not to attack DNA, but to have a novel mechanism of action, meaning that it could not only dramatically slow down and halt cancer growth, but also significantly reduce the side effects suffered by patients” argues Professor Sadler.
This research could also lead to substantial improvements in cancer survival rates. “Current statistics indicate that one in every three people will develop some kind of cancer during their life time, moreover approximately one woman dies of ovarian cancer every two hours in the UK according to Cancer Research UK .It is clear that a new generation of drugs is necessary to save more lives and our research points to a highly effective way of defeating cancerous cells” said Dr Romero-Canelon.
The Latest on: Cancer treatment
[google_news title=”” keyword=”Cancer treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer treatment
- Cancer Treatment Ends, and Death Cab for Cutie’s “What Sarah Said.”on May 7, 2024 at 2:33 pm
It is my sad duty to share that I am out of cards, writes blogger Robin McGee, so all my efforts now will be directed to palliative care.
- Professional Faqs: Is Asparagus Beneficial In The Treatment Of Cancer?on May 7, 2024 at 2:28 pm
Dietetics and Clinical Nutrition Services · 7 years of experience · South AfricaNo, asparagus is not beneficial in the treatment of cancer. Asparagus does contain antioxidants which means it can ...
- Courage in action: Cancer survivors unite at state Capitol to advocate for changeon May 7, 2024 at 1:57 pm
On Tuesday, May 7, cancer patients, survivors, caregivers and cyclists from across the state traveled to the Capitol to ride around the Statehouse and to meet with their elected officials during ...
- Why are Black women more likely to die from breast cancer? A new study is working to find the answeron May 7, 2024 at 1:43 pm
The American Cancer Society is launching a new study aimed at determining why Black women are at higher risks for various types of cancer.
- Minnesota Senate Passes Bill Including Coverage for Cancer Patient Wigs, Minneapolis Senator Advocates Changeon May 7, 2024 at 1:35 pm
Minnesota Senate passes a Health and Human Services bill mandating insurance coverage for cancer patients' wigs, a provision introduced by Senator Kari Dziedzic, who is undergoing cancer treatment.
- Researchers use foundation models to discover new cancer imaging biomarkerson May 7, 2024 at 1:25 pm
Researchers have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified from ...
- Cincinnati Archbishop Dennis Schnurr diagnosed with cancer, will undergo chemotherapyon May 7, 2024 at 12:39 pm
Cincinnati's 75-year-old Catholic archbishop has stage III bowel cancer but intends to continue to work through his chemotherapy treatments ...
- Years after his death, late scientist's work could yield new cancer treatmentson May 7, 2024 at 12:35 pm
Some of the final work of a late University of Virginia School of Medicine scientist has opened the door for life-saving new treatments for solid cancer tumors, including breast cancer, lung cancer ...
- MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution to Prostate Canceron May 7, 2024 at 11:00 am
MemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County – and one of only two in California – to offer a new, innovative way to treat prostate cancer patients ...
- Dogma-challenging telomere findings may offer new insights for cancer treatmentson May 7, 2024 at 2:39 am
A new study led by University of Pittsburgh and UPMC Hillman Cancer Center researchers shows that an enzyme called PARP1 is involved in repair of telomeres, the lengths of DNA that protect the tips of ...
via Bing News